Table 3.
CPCA clinical and genotype variables | Overall | PC1 | PC2 | PC1 + PC2 |
---|---|---|---|---|
Total variance | 26.46 | 9.45 | 8.19 | 17.64 |
% variance | 100.00 | 35.72 | 30.93 | 66.65 |
Variance explained by clinical variables and genotypes | 13.79 | 6.87 | 5.32 | 12.19 |
% variance explained by clinical variables and genotypes | 52.16 | 25.96 | 20.11 | 46.07 |
CPCA clinical × genotype interaction | PC NCFxG | |||
Variance explained by clinical variables × genotypes interaction | 4.72 | 1.34 | – | 1.34 |
% Variance explained by clinical variables × genotypes interaction | 17.84 | 5.08 | – | 5.08 |
Each component accounts for a portion of the total variance: the first component accounts for the largest amount of variance, with each successive component accounting for a smaller amount of the total variance. PC1, principal component 1; PC2, principal component 2; PC1 + PC2, sum of PC1 and PC2; PC NFCxG, interaction term between neonatal clinical factors and genotypes.